239 related articles for article (PubMed ID: 30664123)
1. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
2. LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel).
Sauer L; Vitale AS; Modersitzki NK; Bernstein PS
Retina; 2021 Jul; 41(7):1416-1427. PubMed ID: 34137386
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment.
Sauer L; Andersen KM; Li B; Gensure RH; Hammer M; Bernstein PS
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3094-3103. PubMed ID: 30025128
[TBL] [Abstract][Full Text] [Related]
4. Multifocal electroretinography in patients with macular telangiectasia type 2.
Goel N; Kumari A; Kumar S; Mehta A
Doc Ophthalmol; 2020 Aug; 141(1):15-21. PubMed ID: 31912262
[TBL] [Abstract][Full Text] [Related]
5. FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.
Sauer L; Vitale AS; Andersen KM; Hart B; Bernstein PS
Retina; 2020 Apr; 40(4):695-704. PubMed ID: 31517727
[TBL] [Abstract][Full Text] [Related]
6. RETINAL FLECKS IN STARGARDT DISEASE REVEAL CHARACTERISTIC FLUORESCENCE LIFETIME TRANSITION OVER TIME.
Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS
Retina; 2019 May; 39(5):879-888. PubMed ID: 30985551
[TBL] [Abstract][Full Text] [Related]
7. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.
Sauer L; Vitale AS; Modersitzki NK; Bernstein PS
Eye (Lond); 2021 Jan; 35(1):93-109. PubMed ID: 33268846
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.
Sauer L; Gensure RH; Hammer M; Bernstein PS
Ophthalmol Retina; 2018 Jun; 2(6):587-598. PubMed ID: 30116796
[TBL] [Abstract][Full Text] [Related]
10. Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration.
Dysli C; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2479-87. PubMed ID: 27149697
[TBL] [Abstract][Full Text] [Related]
11. FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES.
Sauer L; Vitale AS; Jacoby RS; Hart B; Bernstein PS
Retina; 2023 Sep; 43(9):1597-1607. PubMed ID: 37263186
[TBL] [Abstract][Full Text] [Related]
12. Fundus Autofluorescence Lifetime Patterns in Retinitis Pigmentosa.
Dysli C; Schuerch K; Escher P; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1769-1778. PubMed ID: 29610860
[TBL] [Abstract][Full Text] [Related]
13. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
14. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
15. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
16. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
[TBL] [Abstract][Full Text] [Related]
18. Multicolor imaging in macular telangiectasia-a comparison with fundus autofluorescence.
Govindahari V; Fraser-Bell S; Ayachit AG; Invernizzi A; Nair U; Nair DV; Lupidi M; Singh SR; Rajendran A; Zur D; Gallego-Pinazo R; Marco RD; Cagini C; Cozzi M; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2379-2387. PubMed ID: 32803329
[TBL] [Abstract][Full Text] [Related]
19. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence Lifetime Patterns of Retinal Pigment Epithelium Atrophy in Patients with Stargardt Disease and Age-Related Macular Degeneration.
Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS
Ophthalmologica; 2020; 243(3):195-206. PubMed ID: 31743906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
